MHA Today | May 8, 2019

May 8, 2019
MHA Today: News for Healthcare Leaders

linkedin twitter facebook
May 8, 2019

MHA Today is provided as a service to members of the Missouri Hospital Association. Additional information is available online at MHAnet.


In This Issue
MHA Releases Analysis Of Medicare Programs And Quality Trends Reports
Department Of Justice Offers New False Claims Act Guidance
HHS Finalizes Rule To Increase Drug Pricing Transparency
March MUR Available On HIDI Analytic Advantage®
DHSS Releases Health Update On Measles Prevention And Testing Recommendations

Advocate
state and federal health policy developments


MHA Releases Analysis Of Medicare Programs And Quality Trends Reports

Staff Contact: Andrew Wheeler

The Missouri Hospital Association released an analysis of the Medicare inpatient prospective payment system value-based purchasing program, the hospital-acquired condition reduction program and the quality trends reports. The VBP reports are limited to inpatient prospective payment system hospitals and include estimated Medicare payment adjustments. The quality program measures trends are available to both IPPS and critical access hospitals. MHA has complimentary, on-demand webinars about the Medicare pay-for-performance programs. Policy and analytic studies, prepared for distribution by the Hospital Industry Data Institute, are available for download to authorized users of HIDI Analytic Advantage®.

Back To Top

 

Regulatory News
the latest actions of agencies monitoring health care


Department Of Justice Offers New False Claims Act Guidance

Staff Contact: Jane Drummond or Meghan Henderson

The Department of Justice announced the release of formal guidance to DOJ litigators relating to earned leniency for defendants in False Claims Act cases. The new guidance explains how the DOJ awards credit to defendants who cooperate with the DOJ during an investigation. The policy permits cooperation credit to be earned by defendants in FCA cases, including during an ongoing investigation, by voluntarily disclosing misconduct unknown to the government, cooperating in an ongoing investigation or undertaking remedial measures in response to a violation of the FCA. The full policy can be found in the Justice Manual Section 4-4.112.

Back To Top


HHS Finalizes Rule To Increase Drug Pricing Transparency

Staff Contact: Andrew Wheeler

The Centers for Medicare & Medicaid Services released a final rule that requires direct-to-consumer television advertisements about prescription pharmaceuticals covered by Medicare and Medicaid to include the list price. This requirement would be placed on such drugs with prices greater than $35 for a month’s supply or the usual course of therapy. HHS Secretary Alex Azar stated, “Requiring the inclusion of drugs’ list prices in TV ads is the single most significant step any administration has taken toward a simple commitment: American patients deserve to know the prices of the health care they receive.” MHA published an issue brief with additional details.

Back To Top

 

HIDI Tech Connect


March MUR Available On HIDI Analytic Advantage®

Staff Contact: Cerise Seifert

Data for the March 2019 monthly utilization report have been posted on HIDI Analytic Advantage® and are available to download for distribution or placement in a network folder. HIDI Analytic Advantage® PLUS has been updated to include this data. Contacts from participating hospitals have been notified by email, and they may download and save the Excel worksheet to a secure network location or PC. The data are encrypted on the site and also during the transmission from HIDI. Once the data have been transferred, it must be secured according to the hospital’s security procedures. April 2019 data are being collected now and are scheduled to be available Wednesday, June 5.

Back To Top

 

Quality and Population Health


DHSS Releases Health Update On Measles Prevention And Testing Recommendations

Staff Contact: Jackie Gatz or Toi Wilde

This week, the Missouri Department of Health and Senior Services released a Health Update, “Measles Prevention and Testing Recommendations for Areas Not Affected by Measles Outbreaks, Including Missouri.” The update includes a current summary of 704 confirmed measles cases in 22 states. While Missouri has one confirmed measles case in calendar year 2019, it is not included in the outbreak classification list. Therefore, the MMR vaccine schedule recommendations have not changed at this time. There is no recommendation from the Centers for Disease Control and Prevention for vaccination campaigns among adults or individuals in nonaffected areas to prevent measles outbreaks. Health care organizations should isolate suspected measles case-patients, and immediately report suspected cases to the local public health agency or to DHSS at 573/751-6113 or 800/392-0272 (24/7). To ensure prompt public health response, do not wait for laboratory confirmation.

Back To Top

 


Consider This ...

About 700 women die from pregnancy-related complications each year in the U.S., and about 60 percent of those deaths are preventable.

Source: Centers for Disease Control and Prevention